Methods of Mesenchymal Stem Cell Homing to the Blood-Brain Barrier
- PMID: 30196403
- DOI: 10.1007/978-1-4939-8697-2_6
Methods of Mesenchymal Stem Cell Homing to the Blood-Brain Barrier
Abstract
Mesenchymal stem/stromal cells (MSC) are multipotent cells that can be isolated from adult and fetal tissues. In vitro, MSCs show functional plasticity by differentiating into specialized cells of all germ layers. MSCs are of relevant to medicine and have been proposed for several disorders. MSCs can be transplanted across allogeneic barriers as "off the shelf" cells. This chapter focuses on methods to deliver MSCs to the brain because neurological pathology such as damage due to stroke can lead to debilitating mental and physical problems. In general, neurological diseases are difficult to treat, partly due to the challenge in getting drugs across the blood-brain barrier (BBB). MSCs as well as other stem cells can cross the BBB. The described method begins to develop procedures, leading to efficient delivery of drugs to the brain. Here describe how MSCs can be propagated from bone marrow aspirates and their utility in delivering small RNA to the brain. The chapter discusses the issue to enhance efficient delivery of MSCs to the brain.
Keywords: Blood–brain barrier; Bone marrow; Drug delivery; Mesenchymal stem cell; Noncoding RNA.
Similar articles
-
Effects of over-expression of SOD2 in bone marrow-derived mesenchymal stem cells on traumatic brain injury.Cell Tissue Res. 2018 Apr;372(1):67-75. doi: 10.1007/s00441-017-2716-7. Epub 2017 Oct 30. Cell Tissue Res. 2018. PMID: 29082445
-
In utero transplantation of human bone marrow-derived multipotent mesenchymal stem cells in mice.J Orthop Res. 2006 Mar;24(3):301-12. doi: 10.1002/jor.20047. J Orthop Res. 2006. PMID: 16482576
-
Targeted homing of CCR2-overexpressing mesenchymal stromal cells to ischemic brain enhances post-stroke recovery partially through PRDX4-mediated blood-brain barrier preservation.Theranostics. 2018 Nov 12;8(21):5929-5944. doi: 10.7150/thno.28029. eCollection 2018. Theranostics. 2018. PMID: 30613272 Free PMC article.
-
Cell Therapy of Stroke: Do the Intra-Arterially Transplanted Mesenchymal Stem Cells Cross the Blood-Brain Barrier?Cells. 2021 Nov 3;10(11):2997. doi: 10.3390/cells10112997. Cells. 2021. PMID: 34831220 Free PMC article. Review.
-
Mesenchymal stem cells.Cell Transplant. 2011;20(1):5-14. doi: 10.3727/096368910X. Cell Transplant. 2011. PMID: 21396235 Review.
Cited by
-
[18F]FDG-labelled stem cell PET imaging in different route of administrations and multiple animal species.Sci Rep. 2021 May 25;11(1):10896. doi: 10.1038/s41598-021-90383-4. Sci Rep. 2021. PMID: 34035416 Free PMC article.
-
Differentiation of Mesenchymal Stem Cells to Neuroglia: in the Context of Cell Signalling.Stem Cell Rev Rep. 2019 Dec;15(6):814-826. doi: 10.1007/s12015-019-09917-z. Stem Cell Rev Rep. 2019. PMID: 31515658 Free PMC article. Review.
-
Mesenchymal Stem Cells as a Gene Delivery Tool: Promise, Problems, and Prospects.Pharmaceutics. 2021 Jun 7;13(6):843. doi: 10.3390/pharmaceutics13060843. Pharmaceutics. 2021. PMID: 34200425 Free PMC article. Review.
-
The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients.Stem Cells Int. 2020 Sep 24;2020:8835986. doi: 10.1155/2020/8835986. eCollection 2020. Stem Cells Int. 2020. PMID: 33014070 Free PMC article. Review.
-
Mesenchymal-Stem-Cell-Based Therapy against Gliomas.Cells. 2024 Apr 2;13(7):617. doi: 10.3390/cells13070617. Cells. 2024. PMID: 38607056 Free PMC article. Review.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
